儿童青少年注意缺陷多动障碍与后续精神病性障碍风险的系统综述与荟萃分析
亚组分析未发现精神病性障碍或精神分裂症结局、研究设计及调整与否的组间显著差异。
要点
- 儿童期ADHD与后续精神病性障碍风险显著增加相关,合并相对效应4.74。
- 亚组分析显示精神病性障碍与精神分裂症结局间无显著组间差异。
- 需进一步研究机制及ADHD早期干预是否降低后续精神病性障碍风险。
核心结论
- 儿童期ADHD与后续精神病性障碍风险增加相关,合并相对效应为4.74(95%CI 4.11-5.46)。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Scopus、PsycInfo和Web of Science从建库至2020年7月7日,纳入队列和病例对照研究,比较18岁以下ADHD诊断者与无ADHD对照者的精神病性障碍相对风险。
主要发现
- 儿童期ADHD诊断与后续精神病性障碍风险显著增加相关,合并相对效应4.74(95%CI 4.11-5.46;I2=43% [95%CI 0%-70%])。
- 亚组分析未发现精神病性障碍(OR 5.04;95%CI 4.36-5.83)与精神分裂症(OR 4.59;95%CI 3.83-5.50)结局间的显著组间差异。
- 队列研究(OR 4.64;95%CI 4.04-5.34)与病例对照研究(OR 6.81;95%CI 4.21-11.03)间无显著组间差异。
- 调整估计(OR 4.72;95%CI 4.11-5.46)与未调整估计(OR 3.81;95%CI 1.39-10.49)间无显著组间差异。
- 以性别和偏倚评分为协变量的Meta回归不显著,未发现发表偏倚证据。
关键数值与推荐
- ADHD暴露与精神病性障碍结局均基于国际分类诊断。
- 合并相对效应采用随机效应模型计算。
临床怎么用
- 临床应关注儿童期ADHD患者后续精神病性障碍的风险,但需进一步研究明确机制及早期干预是否降低风险。
局限性
- 需要进一步研究确定连接这些常见疾病的机制,以及ADHD早期干预是否可能降低后续精神病性障碍风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Growing evidence supports an association between attention-deficit/hyperactivity disorder (ADHD) in childhood and subsequent psychotic disorders. Both disorders share physiopathological features such as attention deficits, dopaminergic imbalance, and genetic susceptibility. However, the results of epidemiologic studies have been conflicting. OBJECTIVE: To provide a quantitative synthesis of studies exploring the association between ADHD and the risk of subsequent psychotic disorder. DATA SOURCES: A systematic literature search of the MEDLINE, Scopus, PsycInfo, and Web of Science databases was performed from inception until the final analysis on July 7, 2020. No restriction of language was applied. STUDY SELECTION: Cohort and case-control studies examining the relative risk of developing a psychotic disorder in people diagnosed with ADHD at younger than 18 years compared with control individuals without ADHD. DATA EXTRACTION AND SYNTHESIS: Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines were followed in reporting results. Two independent reviewers extracted the data and assessed the risk of bias of individual studies using the Newcastle-Ottawa Scale. Preferably adjusted odds ratios (aORs) or hazard ratios from the identified studies were extracted, and ORs were computed when they were not adjusted. A random-effects model was used to calculate the pooled relative effect using the meta package in R. MAIN OUTCOMES AND MEASURES: An association between ADHD (exposure) and psychotic disorder (outcomes); both diagnoses were based on international classification. RESULTS: A total of 15 studies were included in the review. Twelve studies were pooled in the meta-analysis, representing 1.85 million participants. A diagnosis of ADHD in childhood was associated with a significant increase in the risk of subsequent psychotic disorder, with a pooled relative effect of 4.74 (95% CI, 4.11-5.46; I2 = 43% [95% CI, 0%-70%]). No significant between-group differences were found for subgroup analyses according to psychotic disorder (odds ratio [OR], 5.04; 95% CI, 4.36-5.83) or schizophrenia (OR, 4.59; 95% CI, 3.83-5.50) outcomes, cohort (OR, 4.64; 95% CI, 4.04-5.34) or case-control (OR, 6.81; 95% CI, 4.21-11.03) study design, and adjusted (OR, 4.72; 95% CI, 4.11-5.46) or unadjusted (OR, 3.81; 95% CI, 1.39-10.49) estimates. Meta-regressions were not significant when sex and bias score were used as covariates. No evidence of publication bias was found. CONCLUSIONS AND RELEVANCE: These findings suggest that childhood ADHD is associated with an increased risk of a subsequent psychotic disorder. Further studies are required to determine the mechanisms linking these common conditions and whether early intervention for ADHD might reduce the risk of subsequent psychotic disorder.
引用
- Nourredine M, Gering A, Fourneret P, et al. Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021. PMID: 33625499. doi:10.1001/jamapsychiatry.2020.4799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。